Vincent Weisser
Co-founder at CryoDAO · Team at Molecule · Co-Founder & CEO at Prime Intellect · Team at VitaDAO
Vincent Weisser is co-founder and CEO of PrimeIntellect and an advisor to Molecule. He graduated from Cord University of Applied Sciences.
Current Roles
News Mentions
Friedberg: New study shows enzyme reverses skin age from 70+ years to 31 Chamath: That’s a $2T market. Did Scientists Just Discover How to Reverse Skin Aging!? “CML is kind of the predominant molecule that gets formed in this extracellular matrix that's driving aging, and nothing breaks it down.
A sugar molecule has been found in space for the first time ever Researchers say it opens "the possibility for life to develop elsewhere in the universe"
this week's been a total win for ai, so many new models and features to try out this weekend: > 1 new frontier model: gpt 5.6 Sol > 2 new crazy cheap models that are 80% frontier: grok 4.5 and meta muse spark 1.1 > 2 new image models: muse image and seedream 5.0 > prime intellect raising $130M t
吴说获悉，去中心化 AI 协议 Prime Intellect 宣布完成 1.3 亿美元 A 轮融资，由 Radical Ventures 领投，NVIDIA Ventures、Intel Capital、Dell Technologies Capital 等参投，总融资额超过 1.5 亿美元。本轮资金将用于构建开放超级智能堆栈，涵盖算力、大规模强化学习、环境、沙盒、评估和部署等。 wublock123.com/news/prime-int…
Prime Intellect CEO @vincentweisser explains why he's betting that the future of AI is self-improving agents. "I think the future that we are starting to see is a lot of these companies want to build self-improving agents." "The way to do this is to have an RL environment for a use case, you scale
Prime Intellect raises $130M Series A to help enterprises build their own AI agents https://techcrunch.com/2026/07/08/prime-intellect-raises-130m-series-a-to-help-enterprises-build-their-own-ai-agents/?utm_source=dlvr.it&utm_medium=twitter
RT @vitadao: Welcoming Michael Torres, Ph.D. (@Mykalt45) as a Core Advisor to VitaDAO. From lab bench → clinic → a ~$300M Eli Lilly acquis…
Hello, my dear friends, we have some breaking news today! Our rentosertib (novel target that has never been in clinical trials before we picked it using AI, novel molecule designed using true generative AI with the published broadly used AI platform, targeting fibrosis and biology of aging) entered
one of the craziest bets of prime intellect was swinging for everything from the start. we operate datacenters, we build our own trainers and envs and sandboxes, we have a platform for large enterprises and solo devs, we train huge models, we publish. ~40 people btw. hiring, DM
RT @DeSciBerlin: Ben Snipes, Chief Legal Officer @Molecule_sci opens Day 2 of DeSci Berlin! How does it work when token holders can also b…